Compare HLF & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLF | ATRC |
|---|---|---|
| Founded | 1980 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2004 | 2005 |
| Metric | HLF | ATRC |
|---|---|---|
| Price | $11.49 | $27.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $18.00 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 1.3M | 692.6K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $5,037,500,000.00 | $201,630,000.00 |
| Revenue This Year | $4.97 | $15.27 |
| Revenue Next Year | $3.80 | $12.21 |
| P/E Ratio | $19.84 | ★ N/A |
| Revenue Growth | 0.89 | ★ 15.40 |
| 52 Week Low | $7.56 | $25.36 |
| 52 Week High | $20.40 | $43.18 |
| Indicator | HLF | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 33.19 | 50.75 |
| Support Level | $8.41 | $25.83 |
| Resistance Level | $13.35 | $30.49 |
| Average True Range (ATR) | 0.48 | 1.18 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 18.98 | 61.13 |
Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.